ImageneBio IMA Income Statement (2020-2026)

NASDAQ IMA
$3.72 -0.09 (-2.36%)
As of: Nov 11, 2026 · 3:56 PM EST
Reported Financials

ImageneBio Quarterly Income Statement

Periods 27 quarters
Latest Sep 2026

ImageneBio reported revenue of $1.19M and net income of -$15.74M for the quarter ended Sep 2026. This income statement covers 27 quarters of results from Mar 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
20.22M3.38M0.38M6.40M5.45M5.31M2.00M1.19M0.66M3.50M0.03M0.80M1.29M1.13M1.25M1.19M
Operating items
Research & DevelopmentR&D
12.34M14.34M15.49M18.85M15.64M15.55M15.17M14.65M14.27M9.65M9.83M3.89M2.53M4.04M5.65M15.16M3.68M5.96M6.67M11.27M
Selling, General & AdministrativeSG&A
5.09M6.00M5.85M5.43M4.93M5.28M5.32M6.03M8.29M6.00M5.31M1.65M17.67M2.76M1.71M11.04M5.23M6.12M5.12M6.04M
Restructuring CostsRestructuring
2.60M0.68M0.81M0.34M1.44M0.31M
Other Operating ExpensesOther Opex
-0.02M0.42M4.08M-1.44M-0.31M2.85M
Operating ExpensesOpex
17.43M20.35M21.33M24.28M20.56M20.83M20.49M20.69M22.57M18.23M15.82M5.54M24.62M6.80M7.36M26.19M8.91M12.08M11.78M17.31M
Operating IncomeOp. Inc
2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.12M-6.00M-7.36M-26.19M-8.91M-12.08M-11.78M-17.31M
Non-operating items
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
-0.48M-0.63M-0.08M0.42M0.27M0.04M0.17M1.01M-0.27M-0.04M0.59M-0.17M0.03M-0.03M0.09M-0.01M-0.10M-0.03M-0.12M
Interest & Investment IncomeInt & Inv Inc
0.01M0.17M0.46M0.55M1.01M1.30M1.38M2.16M2.27M2.11M1.92M1.77M1.57M1.42M1.29M
Other Non Operating IncomeOther Non Op Inc.
0.01M-0.05M0.46M0.01M2.13M0.57M-0.01M0.00M-0.01M-0.01M0.24M-1.19M3.76M-0.01M0.01M0.28M0.43M0.34M0.37M0.52M
Non Operating IncomeNon Op. Inc.
0.01M0.12M0.46M0.54M1.02M1.30M1.38M2.16M2.26M2.11M2.16M-1.15M10.79M-0.08M-0.23M1.34M1.72M1.47M1.62M1.71M
Net income details
EBIT
2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.12M-6.00M-7.36M-26.19M-8.91M-12.08M-11.78M-17.31M
EBT
2.80M-16.79M-20.49M-17.33M-14.10M-14.22M-17.12M-17.34M-19.65M-16.12M-13.67M-3.18M-17.33M-6.08M-7.59M-24.85M-7.18M-10.61M-10.16M-15.60M
Tax ProvisionsTaxes
0.03M0.06M0.15M0.03M0.02M-0.07M0.42M0.01M0.02M0.02M
Income After Tax
2.80M-16.79M-20.49M-17.33M-14.10M-14.22M-17.12M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-7.60M-24.78M-7.61M-10.62M-10.18M-15.62M
Income from Continuing OperationsIncome (Continuing)
2.80M-16.79M-20.49M-17.33M-14.10M-14.22M-17.12M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-7.60M-24.78M-7.61M-10.62M-10.18M-15.62M
Consolidated Net IncomeConsol Net Inc.
2.80M-17.32M-21.12M-17.42M-13.68M-13.95M-17.08M-17.18M-18.48M-16.41M-13.77M-3.18M-4.75M-6.09M-7.60M-24.69M-6.92M-10.72M-10.21M-15.74M
Income towards Parent CompanyParent Net Inc
2.80M-16.84M-20.49M-17.34M-14.10M-14.22M-17.12M-17.34M-19.49M-22.31M-6.26M-3.18M-17.48M-6.08M-7.59M-24.78M-6.91M-10.62M-10.18M-15.62M
Preferred Dividend PaymentsPref Dividends
2.85M2.91M3.00M3.06M3.05M3.15M0.85M
Net Income towards Common StockholdersNet Income
2.80M-16.84M-20.49M-17.34M-14.10M-14.22M-17.12M-17.34M-19.49M-25.17M-9.17M-6.18M-20.54M-9.13M-10.73M-25.63M-6.91M-10.62M-10.18M-15.62M
Additional items
EPS (Basic)
1.20-5.60-6.80-5.74-4.67-4.71-5.23-4.79-5.60-6.26-2.28-1.54-5.11-2.27-2.67-2.91-1.42-0.95-0.63-0.91
EPS (Diluted)
1.20-5.60-6.80-5.74-4.67-4.71-5.23-4.79-5.60-6.26-2.28-1.54-5.11-2.27-2.67-3.01-12.30-0.95-0.63-0.91
Shares Outstanding
2.33M3.01M3.01M3.02M3.02M3.02M3.27M3.62M3.48M4.02M4.02M4.02M4.02M4.02M4.02M8.80M4.87M11.21M16.16M17.12M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
2.33M3.01M3.01M3.02M3.02M3.02M3.27M3.62M3.48M4.02M4.02M4.02M4.02M4.02M4.02M8.53M0.56M11.21M16.16M17.12M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.33M3.01M3.02M3.02M3.02M3.02M3.52M3.68M4.02M4.02M4.02M4.02M4.02M4.02M4.02M8.80M9.28M11.28M16.16M17.12M
EBITDA
2.96M-16.78M-20.80M-17.66M-14.90M-15.28M-18.25M-19.26M-21.60M-18.01M-15.73M-1.95M-28.10M-5.99M-7.36M-26.19M-8.51M-12.08M-11.78M-17.31M

ImageneBio Income Statement API

Pull ImageneBio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY